Comprehensive Single Cell Sequencing Solution from Bio-Rad and Illumina

25 March 2017

Carolyn Reifsnyder, Senior Marketing Manager, Digital Biology Group, Bio-Rad Laboratories, Inc., and Kevin Taylor, PhD, Senior Manager, Market Development, Complex Disease, Illumina, Inc., present a new end-to-end high-throughput next-generation sequencing (NGS) workflow for single-cell gene expression analysis. Learn how Bio-Rad’s droplet digital PCR technology, provides a flexible, scalable and cost-effective solution for single cell preparation for RNA-seq analysis on supporting Illumina platforms. The workflow will enable researchers to differentiate cell populations and sub populations to provide insight into cell fate, population heterogeneity, and transcription regulation in cancer and neurological tissues, and more.